[
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Recent attempts at summarizing reactive astrocyte diversity have shed light on the complex relationships between astrocyte identity and anatomical location, age, sex,73 and pathologic microenvironments.74\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BM, brain metastases; HMGB1, high mobility group box 1; JNK, Janus kinase; LIF, leukemia inhibitory factor; lncRNA-ATB, long non-coding RNA activated by transforming growth factor β; POSTN, periostin; SRGN, serglycin.Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).Structural Communication\nRecent studies have shed light on the critical involvement of extracellular vesicles (EVs) and gap junctions in mediating the bidirectional communication between astrocytes and GB.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, through reprogramming initiated by the tumor microenvironment, astrocytes ultimately exacerbate the tumor progression (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Soluble Factors\nEpithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Epithelial-to-mesenchymal transition–like processes are observed both in GB and astrocytes, particularly at the tumor edge, induced by crosstalk between reactive astrocytes and GB cells10, 11, 12, 13, 14, 15, 16, 17, 18 (Figure 1A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experiments of co-culturing astrocytes and GB cells revealed a transition to a mesenchymal state of the tumor cells, associated with accelerated progression and poor survival outcomes in preclinical models.10 Interestingly, evidence of GB–astrocyte paracrine signaling can be detected in meta-analyses of clinical samples with high astrocyte signature score from The Cancer Genome Atlas.11 In this study, authors identified GB overexpression of periostin (POSTN) and serglycin (SRGN), two secreted factors mediating astrocytic recruitment and activation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Activation of this CHI3L1–IL13Rα2 axis initiates the downstream mitogen-activated protein kinase and protein kinase B signaling pathways, consequently promoting GB cell proliferation.13 Globally, tumor-associated astrocytes secrete a range of factors known to accelerate tumor growth and stimulate GB cell invasion and extracellular matrix remodeling (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The IL-6–MMP14 axis plays a critical role in promoting glioma migration and invasion14 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In addition, glioma-initiating cells undergo a transition to a reactive state exhibiting mesenchymal-like features and gene expression profiles akin to reactive astrocytes.16 To potentiate the release of these astrocyte-soluble factors in a paracrine loop manner, GB cells secrete transforming growth factor-β, fibroblast growth factor, epidermal growth factor, MMPs, and IL-6 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These secreted molecules from GB cells fuel astrogliosis, albeit with potential variations compared with the epithelial-to-mesenchymal transition as described for epithelial tumors16, 17, 18 (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Experimental combined therapy involving ion channel/ion transporter inhibitors with the therapy of reference, temozolomide, exhibited enhanced apoptosis of GB cells in both in vivo and in vitro settings19,20 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EVs are used by tumor cells as carriers for RNA, DNA, receptors, and proteins, including MMP2, MMP9, high mobility group box 1 (HMGB1), and CD147 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Those EVs have been shown to contain miRNAs, epidermal growth factor, fibroblast growth factor, IL-19, and colony-stimulating factor (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This can be directly quantified from increased temozolomide-induced apoptosis in tumor cells expanded in monocultures compared with astrocyte tumor cell co-cultures.37 This chemoresistance is mediated by GB–astrocyte cell–cell contacts and the gap junction protein connexin 43 (Cx43)24, 25, 26, 27 (Figure 1B and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Bentamapimod down-regulates expression of Cx43, potentially offering a strategy to overcome Cx43-mediated treatment resistance in GB25 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surgical intervention disrupts the tumor microenvironment, including astrocytic injuries leading to transcriptome and secretome modifications, promoting tumor proliferation and migration10 (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "During neuron axon regeneration and astrocyte reactivity, mitochondria transit between cells occurs through intercellular connections facilitated by the growth-associated protein 43 (GAP43) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Key molecules promoting synaptogenesis and enhancing tumor growth30,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 59,75, 76, 77, 78, 79, 80, 81, 82, 83 have been summarized in Figure 2 and Table 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NGLN-3 can be shed by disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) proteolytic activity, which classically disconnects synapses40,41 (Figure 2A and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In brain cancer, soluble NGLN-3 binds to glioma cell surface (Figure 2A), activating focal adhesion kinase and the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From a mechanistic standpoint, oligodendrocytic transition is mediated by SOX10 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The central molecule involved in this integration is the synaptogenic factor thrombospondin-1 (TSP-1) (Figure 2C), which is notably known for its involvement in neural circuit remodeling of the healthy brain.43 To disconnect neoplastic synapses in GB, the authors used the TSP-1 inhibitor gabapentin, an anticonvulsant approved by the US Food and Drug Administration for the treatment of epileptic seizures.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional synaptic markers such as Cx43, Gap43, and Ttyh1 have been identified as drivers of neuronal network formation, axon outgrowth, tumor invasion, and therapy resistance (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Increased tumor cell connectivity further promotes cell invasion, proliferation, and axonal outgrowth44 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Recent developments in neuro-oncology have identified four emerging fields: electrochemical neural–cancer interactions, paracrine neural interactions, systemic neural interactions, and cancer therapy effects on the nervous system.75 However, not all neuronal paracrine signaling promotes GB progression (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This leads to different electrochemical phenotypes, including epileptiform neuronal firing, or synchronized atypical short or long-lasting oscillations.47 Among neurotransmitters funneled by GB cells, glutamate plays a pivotal role in tumor proliferation and invasion (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "GB cell connectivity to neuronal networks further relies on M3 muscarinic acetylcholine receptors (CHRM3)78 (Figure 2C and Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among identified neurotransmitters, dopaminergic, glutamatergic, and cholinergic elements of language were used by neurons to communicate with tumor cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Glutamate serves as a potent growth enhancer, whereas GABA, the central inhibitory neurotransmitter, counteracts this effect (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This auto/paracrine signaling has initially been shown to slow glioma proliferation mediated by the histone H2AX phosphorylation79 (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  }
]